
Alliance delivers memo to Trump administration

Little more than 10 weeks pass between a presidential election and the winner’s inauguration. In that time, a group of politically connected advisors called the transition team help the president set priorities, outline policy plans, and prepare budget timelines. It’s also the first chance non-governmental organizations have to make an impression on the incoming administration.
A common method for educating a new administration about an organization’s cause — and sharing how the president can improve the situation for the American people — is through a document called a transition memo.
In December, the Colorectal Cancer Alliance provided the incoming Trump administration with a transition memo detailing the devastating ways colorectal cancer affects Americans and how the president can improve research, patient care, and prevention. Points were made about the rise of young-onset CRC, disparities in research funding, and colorectal cancer’s deadly impact in rural communities and among veterans.
Among its proposals, the Alliance appealed for significant National Cancer Institute funding to focus on colorectal cancer research, including $100 million earmarked for research into young-onset CRC. The memo also appeals to expand biomarker testing, telehealth benefits, and women’s health, and it emphasizes the importance of zero-cost preventive services.
Since the inauguration, the Alliance has been engaged with the new administration, sharing the memo with key stakeholders and visiting Capitol Hill to encourage support. And with recent developments, the Alliance will continue advocating to protect our nation’s health and research infrastructure. As more political appointees fill their positions, the opportunity to engage on behalf of our community grows.
You can read the full transition memo, which details how President Trump could help end colorectal cancer, here.
Top resources

Statement: SCOTUS Decision in Kennedy v. Braidwood Management, Inc.
The Colorectal Cancer Alliance applauds the Supreme Court’s decision in Kennedy v. Braidwood, preserving no-cost preventive care under the ACA—including lifesaving colorectal cancer screenings.

Project Cure CRC Continues to Fuel Urgently Needed Research Funding
The Alliance's Project Cure CRC announces $1.3 million in new research grants — bringing total funding to nearly $12 million — to drive breakthroughs in colorectal cancer care and address critical research gaps.

Alliance Honors Survivors, Encourages Screening and Advocates for Research During National Cancer Survivors Month
In recognition of National Cancer Survivors Month this June, the Colorectal Cancer Alliance (Alliance) is shining a light on the more than 1.5 million colorectal cancer survivors in the United States, celebrating their strength while calling attention to increasing rates of colorectal cancer and the urgent need for more screening and research to end the disease.